COMMUNIQUÉS West-GlobeNewswire
-
Tilray Brands Publishes New Investor Presentation Highlighting Leadership Across Beverage, Cannabis and Wellness Industries, Showcasing Its Global Growth Strategy and Transformation into a Diversified CPG Powerhouse Shaping the Future of Consumer Products
17/11/2025 -
Results of Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) in Children with Achondroplasia Published in JAMA Pediatrics
17/11/2025 -
Invivyd Announces Proposed Public Offering of Common Stock
17/11/2025 -
Kraig Biocraft Laboratories Fulfilling Order for Customized Spider Silk Application from Leading Performance Sports Brand
17/11/2025 -
Protext Mobility, Inc. (OTC: TXTM) Announces Strategic TruLeaf Partnership & Next-Level Innovation
17/11/2025 -
Neocis Unveils Next-Generation AI-Powered Robotic System for Dental Implants
17/11/2025 -
Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)
17/11/2025 -
OSE Immunotherapeutics Announces Positive Recommendation from Independent Data Monitoring Committee (IDMC) to Continue Pivotal Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer
17/11/2025 -
OSE Immunotherapeutics annonce que le Comité indépendant d’experts scientifiques (IDMC) recommande la poursuite d’ARTEMIA, l’essai pivot de Phase 3 de Tedopi® dans le cancer du poumon non à petites cellules
17/11/2025 -
New therapeutic approach to facilitate healing of bed sores
17/11/2025 -
Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections
17/11/2025 -
Vital Nutrients Releases Clinical Findings Showing Plant-Based Cortisol Balance Improves Sleep, Mood, and Stress Response
17/11/2025 -
FDA Grants Fast Track Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer
17/11/2025 -
Positron Corporation Announces Its Transition to a Reporting SEC Company
17/11/2025 -
Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
17/11/2025 -
Corza Medical Launches SensorTek™ ROP Kit: The First and Only Single-Use Kit with Integrated Lens for Retinopathy of Prematurity Exams
17/11/2025 -
Ohio State’s Center for Psychedelic Drug Research and Education collaborates with MAPS for the Ohio P.E.A.C.E. program
17/11/2025 -
JenaValve Announces 1,000th Case with the Trilogy™ Transcatheter Heart Valve (THV) System
17/11/2025 -
Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations
17/11/2025
Pages